The dietary supplement industry experienced two once-in-a-decade events in 2007: the implementation of a serious adverse event reporting (SAER) law and the publication of the long-awaited final rule on good manufacturing practices (GMPs) for supplements. These are the most significant regulatory events to hit the dietary supplement industry since the passage of the Dietary Supplement Health and Education Act (DSHEA) in 1994.
Supplement companies' compliance with the serious adverse event reporting requirements of the Nonprescription Drug and Dietary Supplement Consumer Protection Act recently surpassed the six-month mark. And on June 25, 2008,...
Sign in to view
the full article
This article is part of our paid subscription packages. You need to subscribe (and sign in) to gain access to this Subscriber Only Content.
Why Subscribe to Nutrition Business Journal?
- In-depth perspective on the $226 billion global nutrition industry
- Receive monthly issues and access up to 5 years of back issues
- Downloadable data files, presentations, and more